These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 39899)

  • 41. [Hemodynamic changes during exertion in patients with hypertension treated with propranolol].
    Minovich AI; Chikviladze RI
    Kardiologiia; 1982 May; 22(5):108-9. PubMed ID: 7098268
    [No Abstract]   [Full Text] [Related]  

  • 42. [The effect of obzidan on the cardiohemodynamics of subjects with an artificial pacemaker who have hypertension].
    Iskenderov BG
    Lik Sprava; 1997; (5):117-20. PubMed ID: 9491716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adrenergic beta receptor blockade: hemodynamic importance of intrinsic sympathomimetic activity at rest.
    Svendsen TL; Hartling OJ; Trap-Jensen J; McNair A; Bliddal J
    Clin Pharmacol Ther; 1981 Jun; 29(6):711-8. PubMed ID: 6112090
    [No Abstract]   [Full Text] [Related]  

  • 44. Hemodynamic and pharmacological aspects of the biphasic pressor response to acetylcholine in atropinized dogs.
    Wellens D; Wauters E; Szigetvari E
    Experientia; 1972 Aug; 28(8):940-1. PubMed ID: 4403938
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of some properties of pronethalol and propranolol. 1965.
    Black JW; Duncan WA; Shanks RG
    Br J Pharmacol; 2010 Jul; 160 Suppl 1(Suppl 1):S28-42; discussion S26-7. PubMed ID: 20590649
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hemodynamic effect of propranolol in permanent arterial hypertension].
    Safar M; Weiss Y; Milliez P
    Sem Hop Ther; 1976 Mar; 52(3):163-4. PubMed ID: 1006314
    [No Abstract]   [Full Text] [Related]  

  • 47. Autonomic blocking drugs on circulatory adaptations at rest and during exercise in man. Pronethalol and poldine in long-term treatment.
    Schröder G
    Acta Med Scand; 1968 Nov; 184(5):347-52. PubMed ID: 4389733
    [No Abstract]   [Full Text] [Related]  

  • 48. Nobel lecture in physiology or medicine--1988. Drugs from emasculated hormones: the principle of syntopic antagonism.
    Black J
    In Vitro Cell Dev Biol; 1989 Apr; 25(4):311-20. PubMed ID: 2565896
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacokinetics of bufuralol in man].
    Balant L; Francis RJ; Tschopp JM; Tinguely D; Estreicher J; Fabre J
    Pharm Acta Helv; 1978; 53(11):307-13. PubMed ID: 34170
    [No Abstract]   [Full Text] [Related]  

  • 50. Bufuralol, a new beta-adrenoceptor blocking agent. Part 1: synthesis and structure-activity studies in a series of benzofuran-2-ethanolamines.
    Fothergill GA; Osbond JM; Wickens JC
    Arzneimittelforschung; 1977; 27(5):978-81. PubMed ID: 18158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A symposium: beta blockers and exercise. Introduction.
    Am J Cardiol; 1985 Apr; 55(10):1D-2D. PubMed ID: 2859787
    [No Abstract]   [Full Text] [Related]  

  • 52. Spectrofluorometric determination of bufuralol in blood and urine.
    de Silva JA; Meyer JC; Puglisi CV
    J Pharm Sci; 1976 Aug; 65(8):1230-33. PubMed ID: 10418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemodynamic effect of angiotensin II in minute amounts. Observations on normal subjects at rest and during exercise.
    SANNERSTEDT R; BOJS G; VARNAUSKAS E
    Scand J Clin Lab Invest; 1963; 15():159-66. PubMed ID: 13976333
    [No Abstract]   [Full Text] [Related]  

  • 54. Relationship between pharmacokinetic and pharmacodynamic behaviour of bufuralol and its metabolite Ro 3-7410 in hypertensive patients.
    Eckert M; Cocco G; Strozzi C; Heizmann P; Sfrisi C
    Eur J Clin Pharmacol; 1983; 24(4):479-84. PubMed ID: 6134625
    [No Abstract]   [Full Text] [Related]  

  • 55. Kinetics and metabolism of (+)-, (-)- and (+/-)-bufuralol.
    Francis RJ; East PB; Larman J
    Eur J Clin Pharmacol; 1982; 23(6):529-33. PubMed ID: 6130953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacodynamic and pharmacokinetic studies on bufuralol in man.
    Pringle TH; Francis RJ; East PB; Shanks RG
    Br J Clin Pharmacol; 1986 Nov; 22(5):527-34. PubMed ID: 2878678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemodynamic changes in hypertensive patients at rest and during physical exercise before and after acute i.v. administration of bufuralol-HCl or propranolol.
    Magometschnigg D; Bonelli J; Kaik G; Rameis H
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):334-40. PubMed ID: 39899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decrease of peripheral resistance after acute intravenous application of a new beta-receptor blocking agents, bufuralol HCl.
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G; Korn A
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):54-8. PubMed ID: 24595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol.
    Magometschnigg D; Bonelli J; Kaik G
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):429-32. PubMed ID: 41815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Exercise hemodynamics and renin before and after acute beta block in patients with essential hypertension].
    Burkart F; Bühler FR; Pfisterer M; Küng M
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1732-5. PubMed ID: 13488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.